Digital Disruption in Diabetes

Add this event to your calendar:
10/05/2017 13:30 10/05/2017 15:00 America/Los_Angeles Digital Disruption in Diabetes JLABS , 3210 Merryfield Row , San Diego , CA 92121 JLABS San Diego together with Janssen R&D false DD/MM/YYYY

Digital Disruption in Diabetes

JLABS , 3210 Merryfield Row , San Diego , CA 92121

May 10, 2017 from 13:30 PM to 15:00 PM (PST)

$10 - $35

Hundreds of millions of people around the globe are affected by diabetes, and that number is on the rise. Unlike many other diseases, treatment for diabetes has been around for almost a century, but as technology today advances faster than ever, digital health solutions are making a game changing impact. From easy to use, connected devices to the accessibility of data in creating personalized treatment, innovators are creating solutions centered around the patient. New technologies that consider individual lifestyle and personal motivation while reducing hassle and improving delivery are paving the way to a healthier future.

Join Johnson & Johnson Innovation, JLABS and Johnson & Johnson Health and Wellness Solutions for a discussion with experts on the latest in digital health innovation in the massive diabetes space. We’ll explore topics such as:

  • Cutting edge digital and device innovations in diabetes diagnosis, treatment and patient management
  • Business models that support these innovations
  • Role of patient behavior in development of solutions
  • How big data is influencing the diabetes landscape
  • Overcoming regulatory challenges in the digital health diabetes space

[moderator] Alexander Grunewald | Global Head – Healthcare Innovation Investment Strategy, Johnson & Johnson Innovation read bio»
Nathaniel Heintzman | Director, Data Partnerships, Dexcom read bio»
Athena Philis-Tsimikas, MD | Corporate Vice President, Scripps Whittier Diabetes Institute read bio»
Sean Saint | CEO, Companion Medical read bio»
Scott Johnson | Communications Lead, mySugr read bio»

11:30 AM | Registration Opens, Networking Lunch
12:00 PM | Panel Discussion and Audience Q&A
1:00 PM | Program Close

Who should attend:
Digital health and medical device companies and startups, entrepreneurs, advisors & investors.

$25 | General Public
$20 | Student/Academic
$35 | At the door

3210 Merryfield Row
San Diego, CA

Speakers' Biographies:

Alexander Grunewald | Global Head – Healthcare Innovation Investment Strategy, Johnson & Johnson Innovation
Alexander leads external innovation in Health Solutions and Digital Health at Johnson & Johnson. His team’s focus areas include improving patient outcomes, enhancing wellness of healthy consumers, driving R&D operational advances, and exploring digital therapeutics and genomics.

Alexander began his career in academia, first as a senior postdoctoral scholar in neuroscience at the California Institute of Technology and then as an assistant professor at the University of Wisconsin-Madison. During that time he was published in numerous important research articles, led a visual neurophysiology research team, and taught neuroscience to undergraduate and graduate students.

He then transitioned into industry where he led client engagements in strategy, sales and operations for healthcare companies as a health care leader at McKinsey & Company in Los Angeles. From there he transitioned to running the Drug Compare business at DestinationRx, Inc., a healthcare IT company. He also served as senior director of corporate strategy and business development at McKesson. In this role, he led his team to define the strategy and M&A for the company’s U.S. Pharma and Specialty businesses.

Alexander has a Ph.D. in Computational Neuroscience from Boston University and a B.Sc. in Mathematics from King’s College in London, England.
Connect with Fran:     Connect on LinkedIn

Nathaniel Heintzman| | Director, Data Partnerships, Dexcom
Nate Heintzman is the Director of Data Partnerships at Dexcom Inc, where he leads efforts to support and expand the diabetes innovation ecosystem through improved 3rd-party access to Dexcom CGM data. Prior to joining Dexcom in early 2014, he directed the Diabetes Informatics + Analytics Lab (DIAL) at the University of California, San Diego (UCSD), where he served as faculty in the School of Medicine’s Division of Biomedical Informatics. Heintzman also has a long history of diabetes advocacy, including his founding role in Insulindependence and volunteering for other diabetes advocacy organizations.

Heintzman received his PhD in Biomedical Science from UCSD and his BA in Biochemistry and Molecular Genetics at Gustavus Adolphus College (St Peter, Minn), and his graduate and postdoctoral research in genomics and bioinformatics was published in Nature. He lives in San Diego, California with his wife, and enjoys spending his spare time surfing, playing bass and keyboard in his rock cover band, and gardening.
Connect with Nate:     Follow on Twitter   Connect on LinkedIn

Athena Philis-Tsimikas, MD | Corporate Vice President, Scripps Whittier Diabetes Institute
Athena Philis-Tsimikas is the Corporate Vice President of the Scripps Whittier Diabetes Institute at Scripps Health and the Director of Community Engagement at Scripps Translational Science Institute in San Diego, California. With over 25 years of experience, she leads the Diabetes Care Line which creates programs, conducts research and delivers diabetes services across 5 Scripps hospitals, 25 outpatient facilities and the community which serves over 50,000 patients with diabetes. She is board certified in the subspecialty of Diabetes and Endocrinology and is an Associate Clinical Professor of Medicine at UCSD’s Division of Endocrinology and Metabolism. She developed and implemented the innovative Project Dulce program which cares for underserved populations with diabetes. Dr. Philis-Tsimikas and Scripps Whittier Diabetes Institute are actively promoting and training community physicians and community health centers to participate in community-based clinical research that will bring innovative health care solutions to their communities.
Connect with Dr. Philis-Tsimikas:   Connect on LinkedIn

Sean Saint | CEO, Companion Medical
Sean Saint is responsible for assembling the corporate team and managing day-to-day operations of the Company. He has over 15 years of engineering experience in medical devices and various startups. Sean is a Type1 diabetic and well known in the diabetes community.

Prior to starting Companion Medical his career has ranged through Director of Advanced Technology and Mechanical Engineer at Tandem Diabetes Care, Co-Founder and Vice President of R&D at Alure Medical, Engineering Manager at Dexcom, and Senior Engineer at Medtronic/AVE. Saint has 75 issued and pending patent applications.

Saint holds a BS in Mechanical Engineering with a minor in Computer Science from California Polytechnic State University, San Luis Obispo and is a registered Professional Engineer in the state of California.
Connect with Sean:   Connect on LinkedIn

Scott Johnson | Communications Lead, mySugr
Scott is an experienced patient advocate. He works with a wide range of stakeholders across the healthcare environment to help them establish effective communication with the patient community. His expertise in the diabetes social media space is recognized worldwide and he advises organizations within the healthcare, food, and consumer goods industries. Today he is Communications Lead, USA for mySugr and Patient Pathways Lead in the Diabetes Division of Delta Project Management. He manages a long-standing and award-winning blog “Scott's Diabetes” that reaches hundreds of thousands of people annually. Scott is also a member of the Children with Diabetes faculty where he develops educational curriculums and content for the Friends for Life annual conference and regional events. He is on the Executive Committee of the Board of Directors for the Diabetes Hands Foundation, the Board of Directors for the Diabetes Community Advocacy Foundation, and is a founding member of Partnering for Diabetes Change, a coalition of people living with diabetes and industry representatives working to support underserved communities. He is interested in how these types of interactions including peer-to-peer support impact patient outcomes and routinely presents his work.
Connect with Scott:   Connect on LinkedIn

JLABS San Diego together with Janssen R&D

Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and healthtech sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to ten global locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto, Beerse (Belgium), with New York City, opening in June 2018, and Shanghai in 2019. For more information please visit or follow @JLABS.

Event contact

Related content